Andrew Mujugira, Beyonce Karungi, Jackson Mugisha, Agnes Nakyanzi, Olivia Nampewo, Faith Naddunga, Brenda Kamusiime, Rogers Nsubuga, Kikulwe R Nyanzi, Timothy R Muwonge, Monique A Wyatt, Norma C Ware, Monica Gandhi, Jessica E Haberer
INTRODUCTION: Adherence counselling with point-of-care (POC) drug-level feedback using a novel tenofovir assay may support pre-exposure prophylaxis (PrEP) adherence; however, perceptions of urine testing and its impact on adherence are not well studied. We qualitatively examined how POC tenofovir testing was experienced by transgender women (TGW) in Uganda. METHODS: Within a cluster randomized trial of peer-delivered HIV self-testing, self-sampling for sexually transmitted infections and PrEP among HIV-negative TGW showing overall low PrEP prevention-effective adherence (NCT04328025), we conducted a nested qualitative sub-study of the urine POC assay among a random sample of 30 TGW (August 2021-February 2022)...
May 2024: Journal of the International AIDS Society